Drug Shortage Report for TEVA-TRIACOMB

Last updated on 2025-05-08 History
Report ID 232735
Drug Identification Number 00550507
Brand name TEVA-TRIACOMB
Common or Proper name TRIACOMB CREAM
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) GRAMICIDIN NEOMYCIN NYSTATIN TRIAMCINOLONE ACETONIDE
Strength(s) 0.25MG 2.5MG 100000UNIT 1MG
Dosage form(s) CREAM
Route of administration TOPICAL TOPICAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 15g
ATC code D07CB
ATC description CORTICOSTEROIDS, COMB WITH ANTIBIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-07-10
Estimated end date 2025-06-10
Actual end date
Shortage status Actual shortage
Updated date 2025-05-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2025-05-08 French Compare
v15 2025-05-08 English Compare
v14 2025-04-24 French Compare
v13 2025-04-24 English Compare
v12 2025-01-16 French Compare
v11 2025-01-16 English Compare
v10 2024-12-04 French Compare
v9 2024-12-04 English Compare
v8 2024-09-19 French Compare
v7 2024-09-19 English Compare
v6 2024-09-05 French Compare
v5 2024-09-05 English Compare
v4 2024-07-26 French Compare
v3 2024-07-26 English Compare
v2 2024-07-11 French Compare
v1 2024-07-11 English Compare

Showing 1 to 16 of 16